HYAL2 and breast carcinoma: This is consistent with the finding that in breast cancer cells, Hyal-2 forms a complex with CD44 and the Na+–H+ exchanger 1 (NHE1), and HA degradation by Hyal-2 depends upon its interaction with CD44 at the membrane surface.